TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ARDX

Ardelyx Inc

Healthcare · Biotechnology

3.60$ +3.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Ardelyx Inc (ARDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 576 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARDX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
289 298 342 343 368 436 410 467 486 503 505 576
241 246 258 263 284 356 313 352 368 382 382 442
34 21 36 42 47 65 31 90 43 68 31 97
165 184 203 186 190 250 214 238 243 265 238 282
43 22 28 37 53 58 46 63 77 72 83 100
8.5 12 9.8 14 11 21 24 22 25 18 23 26
98 131 191 196 210 262 265 327 332 336 356 427
44 50 57 62 70 78 76 82 83 89 110 132
4.3 4.4 4.3 3.6 2.6 1.6 1.3 1.2 1.4 1.5 1.5 1.5
7.7 11 17 11 16 16 14 22 18 19 28 38
27 50 100 100 101 151 151 201 202 203 204 252
191 167 151 147 158 173 146 140 154 167 149 149
-817 -846 -873 -889 -890 -885 -926 -946 -947 -947 -985 -1,001
228 219 233 235 236 244 239 240 242 244 246 248

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?